Suicide mortality in relation to dietary intake of n-3 and n-6 polyunsaturated fatty acids and fish: Equivocal findings from 3 large US cohort studies

American Journal of Epidemiology

Volumn 179, Issue 12, 2014, Pages 1458-1466

  Tsai, Alexander C ^a,b,c   Lucas, Michel ^d,e   Okereke, Olivia I ^b,d,f   O'Reilly, Éilis J ^d,f   Mirzaei, Fariba ^d   Kawachi, Ichiro ^d,f   Ascherio, Alberto ^d,f   Willett, Walter C ^d,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

diet; docosahexaenoic acid; eicosapentaenoic acid; fish; linoleic acid; n 3 polyunsaturated fatty acids; suicide

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

COHORT ANALYSIS; DIET; FISH; FOOD INTAKE; HEALTH SURVEY; MORTALITY; SUICIDE;

ARTICLE; CONTROLLED STUDY; DEATH CERTIFICATE; DIETARY INTAKE; FEMALE; FISH; FOLLOW UP; HUMAN; MALE; MORTALITY; NUTRITIONAL ASSESSMENT; RISK FACTOR; SMOKING; SUICIDE;

UNITED STATES;

DIET; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; FISH; LINOLEIC ACID; N-3 POLYUNSATURATED FATTY ACIDS; SUICIDE;

ANIMALS; COHORT STUDIES; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK; SEAFOOD; SUICIDE; UNITED STATES;

EID: 84902449263     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu086     Document Type: Article

References (76)

1. Hegarty BD, Parker GB. Marine omega-3 fatty acids and mood disorders - linking the sea and the soul. 'Food for Thought' I. Acta Psychiatr Scand. 2011;124(1): 42-51.
2. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12): 1954-1967.
3. Hibbeln Jr. Re: "Fish consumption and major depression" [letter]. Lancet. 1998;351(9110):1213.
4. Tanskanen A, Hibbeln JR, Hintikka J, et al. Re: "Fish consumption, depression, and suicidality in a general population" [letter]. Arch Gen Psychiatry. 2001;58(5): 512-513.
5. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68(2): 140-147.
6. Sanchez-Villegas A, Henríquez P, Figueiras A, et al. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr. 2007;46(6): 337-346.
7. Colangelo LA, He K, Whooley MA, et al. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition. 2009;25(10): 1011-1019.
8. Li Y, Dai Q, Ekperi LI, et al. Fish consumption and severely depressed mood, findings from the first national nutrition follow-up study. Psychiatry Res. 2011;190(1): 103-109.
9. Hakkarainen R, Partonen T, Haukka J, et al. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry. 2004;161(3): 567-569.
10. Lucas M, Mirzaei F, O'Reilly EJ, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr. 2011;93(6): 1337-1343.
11. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009;28(5): 525-542.
12. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010;91(3): 757-770.
13. Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2012;17(12): 1272-1282.
14. Perlis RH. Hard outcomes: clinical trials to reduce suicide [editorial]. Am J Psychiatry. 2011;168(10): 1009-1011.
15. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282(6279): 1847-1851.
16. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1): 32-38.
17. Heron M. Deaths: leading causes for 2008. Natl Vital Stat Rep. 2012;60(6): 1-94.
18. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859): 2095-2128.
19. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23(2): e20-e30.
20. Hirayama T. Lifestyle and Mortality: A Large-Scale Census-Based Cohort Study in Japan. (Contributions to Epidemiology and Biostatistics, vol. 6). New York, NY: S. Karger AG; 1990.
21. Poudel-Tandukar K, Nanri A, Iwasaki M, et al. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women - the Japan Public Health Center-based (JPHC) prospective study. J Affect Disord. 2011; 129(1-3): 282-288.
22. Simopoulos AP. The importance of the ratio of omega-6/ omega-3 essential fatty acids. Biomed Pharmacother. 2002; 56(8): 365-379.
23. Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007; 101(3): 577-599.
24. Sprecher H. An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care. 1999;2(2): 135-138.
25. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 suppl): 1505S-1519S. (Pubitemid 44713092)
26. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985;313(17): 1044-1049.
27. Hennekens CH, Speizer FE, Rosner B, et al. Use of permanent hair dyes and cancer among registered nurses. Lancet. 1979; 313(8131): 1390-1393.
28. Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990; 323(15): 1026-1032.
29. Grodstein F, Colditz GA, Hunter DJ, et al. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol. 1994; 84(2): 207-214.
30. Larsen KK, Agerbo E, Christensen B, et al. Myocardial infarction and risk of suicide: a population-based case-control study. Circulation. 2010;122(23): 2388-2393.
31. Stenager EN, Madsen C, Stenager E, et al. Suicide in patients with stroke: epidemiological study. BMJ. 1998;316(7139): 1206-1210.
32. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366(14): 1310-1318.
33. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1): 51-65.
34. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337(21): 1491-1499.
35. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc. 1993;93(7): 790-796.
36. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001; 285(3): 304-312.
37. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1): 17-27.
38. Raper NR, Cronin FJ, Exler J. Omega-3 fatty acid content of the US food supply. J Am Coll Nutr. 1992;11(3): 304-308.
39. Consumer and Food Economics Institute. Composition of Foods: Raw, Processed, and Prepared. (US Department of Agriculture handbook no. 8).Washington, DC: US GPO; 1989.
40. Garland M, Sacks FM, Colditz GA, et al. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr. 1998;67(1): 25-30.
41. Hu FB, Stampfer MJ, Manson JE, et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69(5): 890-897.
42. Sun Q, Ma J, Campos H, et al. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr. 2007;86(1): 74-81.
43. Hunter DJ, Rimm EB, Sacks FM, et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol. 1992;135(4): 418-427.
44. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287(14): 1815-1821.
45. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001; 345(11): 790-797.
46. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73(2): 209-218.
47. Stampfer MJ,Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119(5): 837-839.
48. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11): 1016-1019.
49. Cox DR, Oakes D. Analysis of Survival Data. London, United Kingdom: Chapman & Hall Ltd.; 1984.
50. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149(6): 531-540.
51. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form general health survey. Reliability and validity in a patient population. Med Care. 1988;26(7): 724-735.
52. Bloch MH, Hannestad J. Response to critiques on 'Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis' [letter]. Mol Psychiatry. 2012;17(12): 1163-1167.
53. Nock MK, Hwang I, Sampson NA, et al. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(8): 868-876.
54. Minkoff K, Bergman E, Beck AT, et al. Hopelessness, depression, and attempted suicide. Am J Psychiatry. 1973; 130(4): 455-459.
55. Beck AT, Steer RA, Kovacs M, et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985;142(5): 559-563.
56. Beck AT, Brown G, Berchick RJ, et al. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990;147(2): 190-195.
57. Durkheim E. Le Suicide: Etude de Sociologie. 2nd ed. (1st ed., 1897). Paris, France: Presses Universitaires de France; 1967.
58. Naroll R. Cultural determinants and the concept of the sick society. In: Plog SC, Edgerton RB, eds. Changing Perspectives in Mental Illness. New York, NY: Holt, Rinehart & Winston Publishing; 1969: 128-155.
59. Bearman PS. The social structure of suicide. Sociol Forum. 1991;6(3): 501-524.
60. Joiner T. Why People Die by Suicide. Cambridge, MA: Harvard University Press; 2005.
61. Van Orden KA, Witte TK, Cukrowicz KC, et al. The interpersonal theory of suicide. Psychol Rev. 2010;117(2): 575-600.
62. Mann JJ. The neurobiology of suicide. Nat Med. 1998;4(1): 25-30.
63. Wells KB, Schoenbaum M, Unützer J, et al. Quality of care for primary care patients with depression in managed care. Arch Fam Med. 1999;8(6): 529-536.
64. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26): 2635-2645.
65. Larson MJ, Miller K, Fleming KJ. Treatment with antidepressant medications in private health plans. Adm Policy Ment Health. 2007;34(2): 116-126.
66. Pagura J, Katz LY, Mojtabai R, et al. Antidepressant use in the absence of common mental disorders in the general population. J Clin Psychiatry. 2011;72(4): 494-501.
67. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8): 848-856.
68. Olfson M, Blanco C, Liu SM, et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12): 1247-1256.
69. Spielmans GI, Berman MI, Linardatos E, et al. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013;10(3):e1001403.
70. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6): 593-602.
71. Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999;2(10): 861-863.
72. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000;24(4): 417-463.
73. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7): 1056-1061.
74. Sublette ME, Ellis SP, Geant AL, et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72(12): 1577-1584.
75. Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. Mol Psychiatry. 2012;17(12): 1144-1149.
76. Lin PY, Mischoulon D, Freeman MP, et al. Re: "Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression" [letter]. Mol Psychiatry. 2012;17(12): 1161-1163.